• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Addressing Health Care Disparities: A Radical Perspective and Proposal.解决医疗保健差异:一种激进的观点与提议。
Front Sociol. 2020 Apr 28;5:29. doi: 10.3389/fsoc.2020.00029. eCollection 2020.
2
Guidelines, editors, pharma and the biological paradigm shift.指南、编辑、制药行业与生物学范式转变
Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.
3
Rethinking the relationship between socio-economic status and health: Making the case for sociological theory in health inequality research.重新思考社会经济地位与健康之间的关系:为健康不平等研究中的社会学理论提供依据。
Scand J Public Health. 2017 Mar;45(2):103-112. doi: 10.1177/1403494816686711. Epub 2017 Jan 12.
4
Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?面向服务不足市场的可负担抗逆转录病毒药物:在充满挑战的情况下如何扩大公平可及性?
Curr HIV Res. 2006 Jan;4(1):3-20. doi: 10.2174/157016206775197592.
5
Intellectual property and access to medicines: an analysis of legislation in Central America.知识产权与药品可及性:中美洲立法分析。
Bull World Health Organ. 2009 Oct;87(10):787-93. doi: 10.2471/blt.08.056010.
6
Intellectual property rights, moral imagination, and access to life-enhancing drugs.知识产权、道德想象力与获取改善生活的药物
Bus Ethics Q. 2005 Oct;15(4):595-613. doi: 10.5840/beq200515441.
7
Finding a place for genomics in health disparities research.在健康差异研究中为基因组学找到一席之地。
Public Health Genomics. 2012;15(3-4):156-63. doi: 10.1159/000334717. Epub 2012 Apr 4.
8
A matter of value. Profits and losses in healthcare.价值问题。医疗保健中的利润与损失。
Health Prog. 1996 May-Jun;77(3):28-34, 48.
9
Outsourced austerity or improved services? A systematic review and thematic synthesis of the experiences of social care providers and commissioners in quasi-markets.外包紧缩还是改善服务?准市场中社会照护提供者和委托者经验的系统评价和主题综合分析。
Soc Sci Med. 2021 May;276:113844. doi: 10.1016/j.socscimed.2021.113844. Epub 2021 Mar 13.
10
Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.成本、承诺与地区性:营利性与非营利性健康保险计划的比较
Inquiry. 2004 Summer;41(2):116-29. doi: 10.5034/inquiryjrnl_41.2.116.

引用本文的文献

1
Shaping the future of kidney genetics in Australia: proceedings from the KidGen policy implementation workshop 2023.塑造澳大利亚肾脏遗传学的未来:2023 年 KidGen 政策实施研讨会的会议记录。
Hum Genomics. 2024 Aug 17;18(1):88. doi: 10.1186/s40246-024-00656-y.
2
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.当代药物研发中的生物碱以满足全球疾病需求。
Molecules. 2021 Jun 22;26(13):3800. doi: 10.3390/molecules26133800.

本文引用的文献

1
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.治愈病态的制药体系:美国和加拿大的改革药方。
BMJ. 2018 May 17;361:k1039. doi: 10.1136/bmj.k1039.
2
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.将抗生素研发投资与销售收入脱钩:将一个有前景的想法转化为现实的挑战。
PLoS Med. 2016 Jun 14;13(6):e1002043. doi: 10.1371/journal.pmed.1002043. eCollection 2016 Jun.
3
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.30个国家丙型肝炎新药的价格、成本及可负担性:一项经济分析
PLoS Med. 2016 May 31;13(5):e1002032. doi: 10.1371/journal.pmed.1002032. eCollection 2016 May.
4
Institutional corruption of pharmaceuticals and the myth of safe and effective drugs.医药行业的体制腐败与安全有效药物的神话。
J Law Med Ethics. 2013 Fall;41(3):590-600. doi: 10.1111/jlme.12068.
5
Pharmaceutical knowledge governance: a human rights perspective.医药知识治理:人权视角。
J Law Med Ethics. 2013 Spring;41(1):163-84. doi: 10.1111/jlme.12012.
6
New drugs and safety: what happened to new active substances approved in Canada between 1995 and 2010?新药与安全性:1995年至2010年间在加拿大获批的新活性物质情况如何?
Arch Intern Med. 2012 Nov 26;172(21):1680-1. doi: 10.1001/archinternmed.2012.4444.
7
Pharmaceutical research and development: what do we get for all that money?药物研发:我们投入那么多资金,收获了什么?
BMJ. 2012 Aug 7;345:e4348. doi: 10.1136/bmj.e4348.
8
Soft currencies, cash economies, new monies: past and present.软通货、现金经济、新货币:过去和现在。
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2214-21. doi: 10.1073/pnas.1118397109. Epub 2012 Jan 31.
9
Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.谁有钱,谁就有证据:制药行业如何影响药物临床试验结果的偏倚。
Sci Eng Ethics. 2012 Jun;18(2):247-61. doi: 10.1007/s11948-011-9265-3. Epub 2011 Feb 15.
10
The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.推销药物的成本:美国药品促销支出的新估算
PLoS Med. 2008 Jan 3;5(1):e1. doi: 10.1371/journal.pmed.0050001.

解决医疗保健差异:一种激进的观点与提议。

Addressing Health Care Disparities: A Radical Perspective and Proposal.

作者信息

Light Donald W

机构信息

Professor of Sociology, Psychiatry and Comparative Health Policy Rowan University School of Osteopathic Medicine, Stratford, NJ, United States.

Princeton University, Princeton, NJ, United States.

出版信息

Front Sociol. 2020 Apr 28;5:29. doi: 10.3389/fsoc.2020.00029. eCollection 2020.

DOI:10.3389/fsoc.2020.00029
PMID:33869437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8022773/
Abstract

This paper begins by rethinking the sociological theory that social conditions are fundamental causes of health disparities and that controlling disease ironically increases or creates them. While usually true, the radical proposal of non-profit health care and pharmaceutical development could ameliorate health disparities if a nation like Canada or a region like the EU looked to radically different but successful models such as the Drugs for Neglected Diseases . It uses what could be called and inverts intellectual property to to maximize health gain instead of profits.

摘要

本文开篇重新审视了一种社会学理论,该理论认为社会状况是健康差距的根本原因,而具有讽刺意味的是,控制疾病反而会加剧或造成这些差距。虽然通常情况确实如此,但如果像加拿大这样的国家或欧盟这样的地区借鉴诸如被忽视疾病药物研发计划等截然不同却成功的模式,非营利性医疗保健和药物研发的激进提议可能会改善健康差距。它采用了所谓的……并颠倒知识产权以……来最大化健康收益而非利润。